These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 37140637)

  • 1. [Reasons for allergology consultations prior to COVID-19 vaccination and their outcomes : Two-year experience of an allergy center in North Rhine-Westphalia].
    Leonidou Floruß E; Demidova A; Hofmann SC; Balakirski G
    Dermatologie (Heidelb); 2023 Jul; 74(7):511-519. PubMed ID: 37140637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination.
    Li L; Robinson LB; Patel R; Landman AB; Fu X; Shenoy ES; Hashimoto DM; Banerji A; Wickner PG; Samarakoon U; Mancini CM; Zhang Y; Blumenthal KG
    JAMA Netw Open; 2021 Oct; 4(10):e2131034. PubMed ID: 34698847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South Australia.
    Tunbridge M; Perkins G; Lee M; Salehi T; Ryoo D; Kette F; Smith W; Gold M; Le TA; Yuson C; Hissaria P
    Intern Med J; 2022 Nov; 52(11):1884-1890. PubMed ID: 35848521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis.
    Chu DK; Abrams EM; Golden DBK; Blumenthal KG; Wolfson AR; Stone CA; Krantz MS; Shaker M; Greenhawt M
    JAMA Intern Med; 2022 Apr; 182(4):376-385. PubMed ID: 35188528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaphylaxis is a rare reaction in COVID-19 vaccination.
    Bellomo RG; Gallenga CE; Caraffa A; Tetè G; Ronconi G; Conti P
    J Biol Regul Homeost Agents; 2021; 35(3):839-842. PubMed ID: 34105336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA).
    Klimek L; Novak N; Hamelmann E; Werfel T; Wagenmann M; Taube C; Bauer A; Merk H; Rabe U; Jung K; Schlenter W; Ring J; Chaker A; Wehrmann W; Becker S; Mülleneisen N; Nemat K; Czech W; Wrede H; Brehler R; Fuchs T; Jakob T; Ankermann T; Schmidt SM; Gerstlauer M; Vogelberg C; Zuberbier T; Hartmann K; Worm M
    Allergo J Int; 2021; 30(2):51-55. PubMed ID: 33643776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed systemic urticarial reactions following mRNA COVID-19 vaccination.
    Pitlick MM; Joshi AY; Gonzalez-Estrada A; Chiarella SE
    Allergy Asthma Proc; 2022 Jan; 43(1):40-43. PubMed ID: 34983709
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk.
    Shavit R; Maoz-Segal R; Iancovici-Kidon M; Offengenden I; Haj Yahia S; Machnes Maayan D; Lifshitz-Tunitsky Y; Niznik S; Frizinsky S; Deutch M; Elbaz E; Genaim H; Rahav G; Levy I; Belkin A; Regev-Yochay G; Afek A; Agmon-Levin N
    JAMA Netw Open; 2021 Aug; 4(8):e2122255. PubMed ID: 34463744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis.
    Briggs FBS; Mateen FJ; Schmidt H; Currie KM; Siefers HM; Crouthamel S; Bebo BF; Fiol J; Racke MK; O'Connor KC; Kolaczkowski LG; Klein P; Loud S; McBurney RN
    Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34753828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of an e-consult program for COVID-19 vaccine allergy concerns.
    Kaddis T; Joshi S; Anstey KM
    Allergy Asthma Proc; 2022 Sep; 43(5):431-434. PubMed ID: 36065101
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence of immediate allergic reactions to mRNA COVID-19 vaccines in adults with drug allergies and other allergic disorders.
    Marković I; Božan M; Perković T; Paušek K; Nedeljković V; Perković M; Kelava T; Artuković M; Stipić Marković A
    Medicine (Baltimore); 2022 Jul; 101(30):e29571. PubMed ID: 35905225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CoronaVac/Sinovac COVID-19 Vaccine-Related Hypersensitivity Reactions and Second-Dose Vaccine Administration: Tertiary Allergy Center Experience.
    Gumusburun R; Dalgıc CT; Mete Gokmen EN; Sin AZ
    Int Arch Allergy Immunol; 2022; 183(7):778-784. PubMed ID: 35462361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccination of patients with allergies and type-2 inflammation with concurrent antibody therapy (biologicals) - A Position Paper of the German Society of Allergology and Clinical Immunology (DGAKI) and the German Society for Applied Allergology (AeDA).
    Pfaar O; Klimek L; Hamelmann E; Kleine-Tebbe J; Taube C; Wagenmann M; Werfel T; Brehler R; Novak N; Mülleneisen N; Becker S; Worm M
    Allergol Select; 2021; 5():140-147. PubMed ID: 33842829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of pediatric patients with suspected polyethylene glycol and polysorbate allergy before mRNA SARS-CoV2 vaccination.
    Karaaslan BG; Burtecene N; Mustu U; Ocak S; Kasapcopur O; Kıykım A; Cokugras H
    Allergol Immunopathol (Madr); 2023; 51(3):174-180. PubMed ID: 37169575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine hesitancy in patients presenting to a specialized allergy center: clinical relevant sensitizations, impact on mental health and vaccination rates.
    Kogseder N; Puxkandl V; Hoetzenecker W; Altrichter S
    Front Immunol; 2024; 15():1324987. PubMed ID: 38827735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staff with a history of allergy.
    Inoue S; Igarashi A; Morikane K; Hachiya O; Watanabe M; Kakehata S; Sato S; Ueno Y
    Respir Investig; 2022 Mar; 60(2):248-255. PubMed ID: 34920980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidating allergic reaction mechanisms in response to SARS-CoV-2 mRNA vaccination in adults.
    Shah MM; Layhadi JA; Hourcade DE; Fulton WT; Tan TJ; Dunham D; Chang I; Vel MS; Fernandes A; Lee AS; Liu J; Arunachalam PS; Galli SJ; Boyd SD; Pulendran B; Davis MM; O'Hara R; Park H; Mitchell LM; Akk A; Patterson A; Jerath MR; Monroy JM; Ren Z; Kendall PL; Durham SR; Fedina A; Gibbs BF; Agache I; Chinthrajah S; Sindher SB; Heider A; Akdis CA; Shamji MH; Pham CTN; Nadeau KC
    Allergy; 2024 Sep; 79(9):2502-2523. PubMed ID: 39033312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older.
    Choi YY; Kim MK; Kwon HC; Kim GH
    J Korean Med Sci; 2021 Nov; 36(45):e318. PubMed ID: 34811980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Allergist Advice in Determining Personal Decisions for COVID-19 Vaccination of People With a History of Allergies.
    Leru PM; Anton V
    Cureus; 2022 Mar; 14(3):e23156. PubMed ID: 35308190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.